These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3549668)

  • 21. Characterization of endemic Providencia stuartii isolates from patients with urinary devices.
    Hollick GE; Nolte FS; Calnan BJ; Penner JL; Barton LJ; Spellacy A
    Eur J Clin Microbiol; 1984 Dec; 3(6):521-5. PubMed ID: 6526019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chromosomal 2'-N-acetyltransferase of Providencia stuartii: physiological functions and genetic regulation.
    Macinga DR; Rather PN
    Front Biosci; 1999 Feb; 4():D132-40. PubMed ID: 9924143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences among Providencia species in their in vitro susceptibilities to five antibiotics.
    Penner JL; Preston MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):868-71. PubMed ID: 7235674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital.
    Tumbarello M; Citton R; Spanu T; Sanguinetti M; Romano L; Fadda G; Cauda R
    J Antimicrob Chemother; 2004 Feb; 53(2):277-82. PubMed ID: 14688041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance factors: influence on netilmicin activity.
    Kallings LO
    Scand J Infect Dis Suppl; 1980; Suppl 23():54-8. PubMed ID: 6937969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase gene from Mycobacterium fortuitum.
    Aínsa JA; Martin C; Gicquel B; Gomez-Lus R
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2350-5. PubMed ID: 8891143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
    Oikonomou O; Liakopoulos A; Phee LM; Betts J; Mevius D; Wareham DW
    Microb Drug Resist; 2016 Jul; 22(5):379-86. PubMed ID: 27380549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
    Kettner M; Krćméry V
    Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

  • 32. The isolation and partial characterization of a new restriction endonuclease from Providencia stuartii.
    Smith DI; Blattner FR; Davies J
    Nucleic Acids Res; 1976 Feb; 3(2):343-53. PubMed ID: 768923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycoside inactivating enzymes produced by R plasmids of Escherichia coli, Citrobacter freundii, Klebsiella pneumoniae, Proteus vulgaris, Providencia stuartii and Serratia marcescens.
    Gómez-Lus R; Rubio Calvo MC; Mur LL
    J Antimicrob Chemother; 1977 Nov; 3 Suppl C():39-41. PubMed ID: 340445
    [No Abstract]   [Full Text] [Related]  

  • 34. Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.
    Marengo PB; Chenoweth ME; Overturf GD; Wilkins J
    Antimicrob Agents Chemother; 1974 Dec; 6(6):821-4. PubMed ID: 4455126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norfloxacin resistance in Providencia stuartii: modifications in DNA-gyrase and permeability.
    Landini P; Pagani L; Cereda PM; Debiaggi M; Romero E
    Biochem Pharmacol; 1988 May; 37(9):1855-6. PubMed ID: 2837244
    [No Abstract]   [Full Text] [Related]  

  • 36. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.
    Jones BD; Mobley HL
    Infect Immun; 1987 Sep; 55(9):2198-203. PubMed ID: 3623698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kanamycin resistance in Providencia stuartii.
    McHale P; English L; Speekenbrink A; Keane C
    J Antimicrob Chemother; 1978 May; 4(3):273-8. PubMed ID: 670120
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmid pattern analysis of natural bacterial isolates and its epidemiological implication.
    Tietze E; Tschäpe H
    J Hyg (Lond); 1983 Jun; 90(3):475-88. PubMed ID: 6345662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.